News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neugenesis Corporation Unveils New Technology For Rapid Production Of Influenza Vaccines



10/19/2005 5:11:57 PM

Neugenesis Corporation today announced the discovery of a method for producing vaccines for influenza and other diseases which radically improves upon current processes. The Neugenesis technology dramatically shortens production time for vaccines, improves sterility in the growth environment, is significantly less expensive and eliminates egg-based allergic reactions. Using the rapid Neugenesis method, vaccine production can occur in as little as 6 weeks in a sterile lab environment, eliminating the traditional reliance upon animal products. The rapid development capability of the Neugenesis technology gives vaccine producers greater flexibility in developing vaccines like the influenza vaccine, where the disease strain may change rapidly. It further minimizes the risk of contamination and offers a new option for those with egg allergies.



comments powered by Disqus
   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES